Copy the page URI to the clipboard
Mileusnic, Radmila and Rose, Steven
(2010).
DOI: https://doi.org/10.4061/2010/180734
Abstract
While animal experiments have contributed much to our understanding of the mechanisms of Alzheimer's disease (AD), their value in predicting the effectiveness of treatment strategies in clinical trials has remained controversial. The disparity between the results obtained in animal models and clinical trials may in part be explained by limitations of the models and species-specific differences. We propose that one trial passive avoidance in the day old chick is a useful system to study AD because of the close sequence homologies of chick and human amyloid precursor protein (APP). In the chick, APP is essential for memory consolidation, and disrupting its synthesis or structure results in amnesia. RER, a tripeptide sequence corresponding to part of the growth domain of APP, can restore memory loss and act as a cognitive enhancer. We suggest that RER and its homologues may form the basis for potential pharmacological protection against memory loss in AD.
Viewing alternatives
Download history
Metrics
Public Attention
Altmetrics from AltmetricNumber of Citations
Citations from Dimensions-
Request a copy from the authorAccepted Manuscript (PDF)
This file is not available for public download - Download Version of Record (PDF / 1MB)
Item Actions
Export
About
- Item ORO ID
- 22355
- Item Type
- Journal Item
- ISSN
- 2090-0252
- Extra Information
-
Special issue on "Animal Models of Alzheimer's Disese".
The journal in which this paper is published is an Open Access journal. The final published version can therefore be accessed for free via the above URL. - Keywords
- memory; Alzheimer's Disease; chicks; peptides; RER
- Academic Unit or School
-
Faculty of Science, Technology, Engineering and Mathematics (STEM) > Life, Health and Chemical Sciences
Faculty of Science, Technology, Engineering and Mathematics (STEM) - Copyright Holders
- © 2010 The Authors
- Depositing User
- Radmila Mileusnic